106 related articles for article (PubMed ID: 16501608)
1. Molecular mechanisms of hyperplasia induction by human papillomavirus E7.
Ueno T; Sasaki K; Yoshida S; Kajitani N; Satsuka A; Nakamura H; Sakai H
Oncogene; 2006 Jul; 25(30):4155-64. PubMed ID: 16501608
[TBL] [Abstract][Full Text] [Related]
2. Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-alpha.
Boccardo E; Manzini Baldi CV; Carvalho AF; Rabachini T; Torres C; Barreta LA; Brentani H; Villa LL
Carcinogenesis; 2010 Mar; 31(3):521-31. PubMed ID: 20042637
[TBL] [Abstract][Full Text] [Related]
3. The role of the human papillomavirus type 18 E7 oncoprotein during the complete viral life cycle.
McLaughlin-Drubin ME; Bromberg-White JL; Meyers C
Virology; 2005 Jul; 338(1):61-8. PubMed ID: 15921717
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
Yugawa T; Kiyono T
Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753
[TBL] [Abstract][Full Text] [Related]
5. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
[TBL] [Abstract][Full Text] [Related]
6. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.
Duensing S; Münger K
Cancer Res; 2002 Dec; 62(23):7075-82. PubMed ID: 12460929
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
8. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7.
Sdek P; Zhang ZY; Cao J; Pan HY; Chen WT; Zheng JW
Int J Oral Maxillofac Surg; 2006 Jul; 35(7):653-7. PubMed ID: 16513324
[TBL] [Abstract][Full Text] [Related]
9. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein.
Caldeira S; de Villiers EM; Tommasino M
Oncogene; 2000 Feb; 19(6):821-6. PubMed ID: 10698500
[TBL] [Abstract][Full Text] [Related]
11. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
12. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
[TBL] [Abstract][Full Text] [Related]
13. High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells.
Bottley G; Watherston OG; Hiew YL; Norrild B; Cook GP; Blair GE
Oncogene; 2008 Mar; 27(12):1794-9. PubMed ID: 17828295
[TBL] [Abstract][Full Text] [Related]
14. E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway.
Contreras-Paredes A; De la Cruz-Hernández E; Martínez-Ramírez I; Dueñas-González A; Lizano M
Virology; 2009 Jan; 383(1):78-85. PubMed ID: 19007961
[TBL] [Abstract][Full Text] [Related]
15. High-risk HPV E6 oncoproteins assemble into large oligomers that allow localization of endogenous species in prototypic HPV-transformed cell lines.
García-Alai MM; Dantur KI; Smal C; Pietrasanta L; de Prat-Gay G
Biochemistry; 2007 Jan; 46(2):341-9. PubMed ID: 17209544
[TBL] [Abstract][Full Text] [Related]
16. Ras modifies proliferation and invasiveness of cells expressing human papillomavirus oncoproteins.
Yoshida S; Kajitani N; Satsuka A; Nakamura H; Sakai H
J Virol; 2008 Sep; 82(17):8820-7. PubMed ID: 18579583
[TBL] [Abstract][Full Text] [Related]
17. The human papillomavirus type 8 E2 protein suppresses beta4-integrin expression in primary human keratinocytes.
Oldak M; Smola H; Aumailley M; Rivero F; Pfister H; Smola-Hess S
J Virol; 2004 Oct; 78(19):10738-46. PubMed ID: 15367640
[TBL] [Abstract][Full Text] [Related]
18. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D
Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269
[TBL] [Abstract][Full Text] [Related]
19. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type 77 E7 protein is a weak deregulator of cell cycle.
Mansour M; Touka M; Malena A; Indiveri C; Dong W; Gionfriddo I; Accardi R; Paradiso A; Sylla BS; Gabet AS; Tommasino M
Cancer Lett; 2007 Feb; 246(1-2):274-81. PubMed ID: 16650526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]